Scientists in Australia have developed a drug that could prevent blindness from cataracts by targeting a specific protein in the eye, according to a FOX News report.
The drug has been effective in preliminary trials but has yet to be tested on humans. Lead investor Professor Andrew Abell, from the University of Adelaide, said the drug could slow cataract growth and possibly make cataract surgery unnecessary.
Cataracts are formed when a protein in the eye, known as calpain, clouds the eye lens and impairs vision. According to the report, the treatment would take the form of drops or cream to be placed in the eye each night before bed.
Related Articles on Ophthalmology:
Product to Treat Pain After Cataract Surgery Meets Study Goals
Sterile Processing of Eye Instruments: Q&A With Nancy Jo Vinson
New Wisconsin Eye Surgery Center Coming to Green Bay
The drug has been effective in preliminary trials but has yet to be tested on humans. Lead investor Professor Andrew Abell, from the University of Adelaide, said the drug could slow cataract growth and possibly make cataract surgery unnecessary.
Cataracts are formed when a protein in the eye, known as calpain, clouds the eye lens and impairs vision. According to the report, the treatment would take the form of drops or cream to be placed in the eye each night before bed.
Related Articles on Ophthalmology:
Product to Treat Pain After Cataract Surgery Meets Study Goals
Sterile Processing of Eye Instruments: Q&A With Nancy Jo Vinson
New Wisconsin Eye Surgery Center Coming to Green Bay